ArticleInvestigational new drugs2014

Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non-small cell lung cancer.

Wilfried E E Eberhardt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.